Sept. 1, 2005 — The U.S. Food and Drug Administration (FDA) and Genentech, Inc., have warned healthcare professionals via letter of study data linking trastuzumab (Herceptin) therapy to a ...
* Says co has filed a lawsuit and a petition for provisional disposition order against Nippon Kayaku Co.,Ltd, demanding the suspension of manufacturing and distribution of the biosimilar of anti-HER2 ...
Herceptin with chemotherapy improved OS and PFS in HER2-positive gastric cancers, but benefits decreased after chemotherapy regimen changes. Major pathological response rates were higher with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results